Seminars in Thrombosis and Hemostasis

Article	Citations
	92
	59
The Next, Next-Generation of Sequencing, Promising to Boost Research and Clinical Practice	56
Thrombotic Antiphospholipid Syndrome and Direct Oral Anticoagulants: Unmet Needs and Review of the Literature	51
Drug–Drug Interactions in the Treatment of Cancer-Associated Venous Thromboembolism with Direct Oral Anticoagulants	43
Prevention of Venous Thromboembolism in Medical Patients with Thrombocytopenia or with Platelet Dysfunction: The Last 10 Years	42
Hemostatic Manifestations of Invasive Fungal Infections: A Comprehensive Review of Pathophysiological Mechanisms in Sepsis-Induced Hemostatic Disturbances, with a Focus on the Neonatal Population	39
Role of Platelets in Rheumatic Chronic Autoimmune Inflammatory Diseases	37
Cancer-Associated Thrombosis: Implications toward Health-Related Quality of Life	35
Fright of Long-Haul Flights: Focus on Travel-Associated Thrombosis	35
Redefining Fibrinolytic Insufficiency in Sepsis-Associated DIC	34
Monitoring Hemostatic Function During Extracorporeal Membrane Oxygenation with Point-of-Care Viscoelastic Assays: A Narrative Review	34
Thrombosis in Antiphospholipid Syndrome: Current Perspectives and Challenges in Laboratory Testing for Antiphospholipid Antibodies	34
Resonant Acoustic Rheometry to Measure Coagulation Kinetics in Hemophilia A and Healthy Plasma: A Novel Viscoelastic Method	32
Testing for Lupus Anticoagulants	31
Thrombin Generation Assays in Clinical Hemostasis: From Mechanistic Insights to Clinical Applications	30
Lupus Anticoagulant-hypoprothrombinemia Syndrome: A Review Enriched by a New Particular Patient	26
Platelet Function Testing: Update and Future Directions	26
Platelet Activation and Thrombosis in COVID-19	26
Application of ACR/EULAR Classification Criteria in Real Life: Thrombotic Patients Positive for Lupus Anticoagulant Only	26
Gut Microbiota and Venous Thromboembolism: An Emerging Link	25
Editorial Compilation—XIII	24
Platelet Function: Acute versus Chronic Responses to Physical Exercise: A Review	24
Anticoagulation Management of Patients with Antiphospholipid Syndrome Undergoing Cardiopulmonary Bypass in Cardiac Surgery: Challenges and Current Strategies	24
The History of Rare Bleeding Disorders	23

External Quality Assessment for Unfractionated Heparin Monitoring: An Update from Australasia/Asia-Pacific	22
How Do Laboratories Perform von Willebrand Disease Diagnostics and Classification of von Willebrand Disease Patients? Results from External Quality Data and an International Survey	22
	22
Evolving Knowledge on Primary and Secondary Prevention of Venous Thromboembolism in Carriers of Hereditary Thrombophilia: A Narrative Review	22
Autoantibodies in Autoimmune Coagulation Factor Deficiencies: A Review of Inhibitory and Clearance-Accelerating Mechanisms from Japanese Practice	21
Anti-platelet Factor 4 Antibody-Mediated Disorders: An Updated Narrative Review	21
Modulating Immune Responses: The Double-Edged Sword of Platelet CD40L	20
Fifty Years of Fibrinogen Structure and Function	19
Gene Therapy for Hemophilia B: Achievements, Open Issues, and Perspectives	19
Toward 50 Years of Seminars in Thrombosis and Hemostasis	19
Evolution of Clinical Trials in Anticoagulation for Sepsis: Bridging Past to Future	19
Celebrating 50 Years of Seminars in Thrombosis and Hemostasis—Part III	18
2022 Eberhard F. Mammen Award Announcements: Part I—Most Popular Articles	18
Association between Severe Acute Respiratory Syndrome Coronavirus 2 Infection (Coronavirus Disease 2019) and Lupus Anticoagulant-Hypoprothrombinemia Syndrome: A Case Report and Literature Assessment	18
Magnetic Resonance Screening for Cerebral Venous Sinus Thrombosis during Treatment with Pegaspargase	18
Patterns of Antiphospholipid Antibody Testing and Positivity in a Real-World Laboratory over Two Decades: The Role of IgM	18
Bleeding in Patients with Renal Impairment: A Current Perspective	18
50 Years of Pediatric Hemostasis: Knowledge, Diagnosis, and Treatment	17
Platelet Function in Patients with Disseminated Intravascular Coagulation: Potential Markers for Improving DIC Diagnosis?	17
Platelet–Red Blood Cell Interactions in Thrombosis: Integrating Hemodynamic, Molecular, and Clinical Evidence–A Systematic Review	16
Investigating a Signal of Acquired Hemophilia Associated with COVID-19 Vaccination: A Systematic Case Review	16
Comprehensive Mendelian Randomization Analysis of Smoking and Its Effects on Venous Thromboembolism	16
	15
	15
Bernard–Soulier Syndrome: A Review of Epidemiology, Molecular Pathology, Clinical Features, Laboratory Diagnosis, and Therapeutic Management	15
Emicizumab in Type 3 von Willebrand Disease: Report of a Case with an Alloantibody and Literature Review	14
Seminars in Thrombosis and Hemostasis: 2024 Impact Factor, Most Highly Cited Papers, and Other Journal Metrics	14
External Quality Assessment Data for Investigation of von Willebrand Disease: Focus on Relative Utility of Contemporary Functional von Willebrand Factor Assays. The United Kingdom National External Qu	14
Mendelian Randomization Provides No Evidence for the Bidirectional Relationship between Type 2 Diabetes and Venous Thromboembolism in East Asians and African Americans	14
In Search of the Perfect Thrombosis and Bleeding-Associated Cancer Scale	14
Reply to the Comment: Research Design Concerns in a TriNetX Analysis of Venous Thromboembolism in Pediatric Cystic Fibrosis Patients	14
Laboratory Testing for the Evaluation of Phenotypic Activated Protein C Resistance	14
Use of Present-on-Admission Indicators to Improve Accuracy of Pulmonary Embolism Identification from Electronic Health Record Data	14
From Ink Pens to Computers: A Personal Look Back at Landmark Changes during 5 Decades as a Clinical Laboratory Scientist in U.S. Hemostasis Laboratories	14
Strength of Anticoagulation in Moderate to Severe COVID-19 Illness: In Medio Stat Virtus?	14
2025 Eberhard F. Mammen Award Announcements–Part II: Young Investigator Awards	14
Automation in Platelet Function Testing: Current Challenges and Future Directions	14
Machine Learning Prediction of Stress-Induced D-dimer Reactivity in Male Physicians with and without Burnout	14
Heparin-Like Anticoagulant: First Case Described in a Metastatic Biliopancreatic Cancer	13
A Brief History of Hemostasis and Thrombosis at the Mayo Clinic	13
Optimizing Venous Stenting: Consensus Recommendations for Enhanced Management of Lower Extremity Deep Vein Thrombosis	13
The Erythrocyte–ROS Axis in Thrombosis and Hemostasis	13
Colchicine as a Modulator of Platelet Function: A Systematic Review	13
Clinical, Laboratory, and Molecular Aspects of Factor V Deficiency	13
Gene Therapy in Hemophilia A: Achievements, Challenges, and Perspectives	13
	13
Physical Activity in People with Hemophilia	13
Neutrophil Extracellular Traps: At the Interface of Thrombosis and Comorbidities	13
Comparative Study of Venous Thromboembolic Prophylaxis Strategies for Patients with Ischemic Stroke: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials	13
Venous Thromboembolism in Children: The Rivaroxaban Experience	12

Dosing Intensity of Anticoagulants for the Prevention and Treatment of Venous Thromboembolism and the Prevention of Stroke in Atrial Fibrillation: Why is There a Difference?	12
Editorial Compilation XIV	12
International Council for Standardization in Haematology Guidance for New Lot Verification of Coagulation Reagents, Calibrators, and Controls	12
COVID-19 Vaccine-Associated Immune Thrombosis and Thrombocytopenia (VITT): Diagnostic Discrepancies and Global Implications	12
Lipopolysaccharide and Coagulation Factor XII: Biophysics of Contact Activation in Infection	12
Red Blood Cell Biomechanics and Cancer-Associated Thrombosis	12
Comparison of Platelet Function Tests for Long-Term Cardiovascular Events after Percutaneous Coronary Interventions	12
	11
COVID-19 and Anticoagulant Use: Did the Pandemic Push DOACs Ahead of Warfarin?	11
Acquired Hemostasis Disorders	11
Editorial Compilation—Part XVIII	11
Decoding Clot Waveform Analysis: Toward Better Understanding and Harmonization	11
Pleiotropic Effects of Heparin and its Monitoring in the Clinical Practice	11
Impact of Hematocrit on Coagulation Measured by Rotational Thromboelastometry in Healthy Subjects and Patients with Polycythemia	11
Pulmonary Embolism-Related Mortality in Femur Fracture Patients: A Recent Retrospective Epidemiological Analysis	11
Bleeding Scoring Systems in Neonates: A Systematic Review	11
Risk Factors for Left Ventricular Thrombus Formation in Patients with Dilated Cardiomyopathy	11
Past, Present, and Future Perspectives of Plasminogen Activator Inhibitor 1 (PAI-1)	11
Clinical Features of Antiphospholipid Syndrome with Intracardiac Mass	11
Mortality from Pulmonary Embolism in Patients with Post-Coronavirus Disease Syndrome	11
A Historical Perspective on the Reversal of Anticoagulants	11
Emicizumab in Acquired Hemophilia A: A Real-World Case Series with Patient-Level Outcome Analysis	11
100 Years of von Willebrand Disease: The Journey to Contemporary Diagnostic Pathways—An Illustrative Case-Based Narrative Review	10
The Applicability of Thromboelastography in Acute Ischemic Stroke: A Literature Review	10
Activated Partial Thromboplastin Time and Prothrombin Time Mixing Studies: Current State of the Art	10
Evaluating Diagnostic Algorithms for Heparin-Induced Thrombocytopenia using Two Combined Automated Rapid Immunoassays	10
D-Dimer Reporting and Harmonization: Analysis of College of American Pathologists D-Dimer Proficiency Testing Program	10
Precision Medicine in Rare Bleeding Disorders	10
Hematohidrosis in 15th Century Renaissance Art and a Review of Modern Literature	10
Platelet Physiology	10
	9
Do we Have the Gut to Beat Thrombosis?	9
A Perspective on How Fibrinaloid Microclots and Platelet Pathology May be Applied in Clinical Investigations	9
Hemostasis Testing in the Emergency Department: A Narrative Review	9
Use of Plasma-Derived FVII Concentrate in Surgical Patients with Factor VII Deficiency: A Case Series	9
Von Willebrand Disease Type 2A: An Update	9
Molecular Mimicry between hPF4 and SARS-CoV-2 Spike Protein: Response to Comment	9
The Role of Platelets in Atherosclerosis: A Historical Review	9
Cancer-Associated Thrombosis and Beyond: Biomarkers, Treatments, and Cancer-Hemostasis Interactions	9
Safety and Efficacy of Therapeutic Anticoagulation with Subcutaneous Unfractionated Heparin in Patients with Renal Failure	9
Transitioning of Patients from Direct-Acting Oral Anticoagulant to Heparin: Impact on Laboratory Testing	9
National Early Warning Score-2 for Identification of Patients with Intermediate-High-Risk Pulmonary Embolism	9
Heterogeneity Among Plasma-Derived von Willebrand Factor Concentrates: Implications for Comparative Effectiveness Analyses	9
Emerging Use of Viscoelastography in Thrombosis and Hemostasis: A Challenge to Conventional Coagulation Tests? Part I: The Use of Thromboelastography and Thromboelastometry in the Assessment of Hemost	9
Thrombin Generation Assays: What are the Current Clinical Applications?	9
The Pathophysiological Role of Platelet-Derived Extracellular Vesicles	9
	9
NETosis in Acute Thrombotic Disorders	9
Current Diagnosis of von Willebrand Disease in Italy: 3 Years Following the Release of the International Guidelines	9
Non-factor Therapies for Hemophilia: Achievements and Perspectives	9
Evolution of Antiphospholipid Syndrome	8
Internal Quality Control in Hemostasis Assays	8
Increased HDL-C Values and Mortality: Revolutionizing a Historical Paradigm?	8
Advances in the Management of Coagulopathy in Trauma: The Role of Viscoelastic Hemostatic Assays across All Phases of Trauma Care	8
Crucial Stepping Stones in Platelet History	8
Laboratory Testing for Fibrinogen Disorders: From Routine Investigations to Research Studies	8
The More Recent History of Hemophilia Treatment	8
Laboratory Testing for ADAMTS13 for Thrombotic Thrombocytopenia Purpura and Beyond	8
Why Does Rivaroxaban Not Work in Severe Mitral Stenosis?	8
It Is Proposed That Cardiovascular Functions are Regulated by the Status of Ecto-phosphoproteins Orchestrated by Platelets	8
Discordant High Activated Partial Thromboplastin Time Relative to Anti-Xa Values in Hospitalized Patients is an Independent Risk Factor for Increased 30-day Mortality	8
2022 Eberhard F. Mammen Award Announcements: Part II—Young Investigator Awards	8
PFA-100 System: A New Method for Assessment of Platelet Dysfunction	8
Current Understandings on Biological Characteristics of Thrombolytics in Acute Ischemic Stroke	8
	7
Hemostatic Aspects of Interactions Between Anticancer Drugs and Oral Anticoagulants in Patients with Cancer-Associated Venous Thromboembolism	7
Dysregulation of the FVIII–VWF Axis in Early-Onset Ischemic Stroke	7
Nebulized Heparin in 2025: at the Interface between Promising Benefits and the Need for Further Research	7
Advanced Treatment of Hemodynamically Unstable Acute Pulmonary Embolism and Clinical Follow-up	7
Cellular Components Contributing to the Development of Venous Thrombosis in Patients with Pancreatic Cancer	7
How Do Muscles Protect Joints in Hemophilia? Integrating Mechanical, Neural, and Endocrine Mechanisms	7
D-dimers—“Normal” Levels versus Elevated Levels Due to a Range of Conditions, Including “D-dimeritis,” Inflammation, Thromboembolism, Disseminated Intravascular Coagulation, and COVID-19	7
One Hundred Years of Congenital Fibrinogen Disorders	7
Risk Factors for Major Adverse Cardiovascular Events and Major Adverse Limb Events after Venous Thromboembolism: A Large Prospective Cohort Study	7
Clinical, Laboratory, and Molecular Aspects of Factor VII Deficiency	7
Antiplatelet Therapy in Coronary Artery Disease: Now and Then	7
Factor Replacement Treatment for Hemophilia A: Achievements and Perspectives	7
Next-Generation Sequencing and Emerging Technologies*	7
New Seminars in Thrombosis and Hemostasis (STH) 2021 Impact Factor, Most Highly Cited Papers, and Other Journal Metrics	7
Limb Ischemic Necrosis Secondary to Microvascular Thrombosis: A Brief Historical Review	7

Comparison of Thrombophilia Assay Results for the International Society on Thrombosis and Haemostasis Scientific and Standardization Committee Plasma Standard from Different External Quality Assessmen	7
A Novel Variant on the Thrombospondin Type-1 Repeat 2 Domain of ADAMTS13 in a Parturient with Suspected Hereditary Thrombotic Thrombocytopenic Purpura and Unusually High ADAMTS13 Activity	6
Deep Vein Thrombosis in Adults with HIV: A Systematic Review and Meta-analysis of Prevalence and Risk Factors	6
Platelets in Neonatal Sepsis: Beyond Clotting, From Silent Players to Immune Orchestrators	6
Nonsevere Hemophilia: The Need for a Renewed Focus and Improved Outcomes	6
Unlocking the Potential of MicroRNA Expression: Biomarkers for Platelet Reactivity and Coronary Artery Disease	6
Congenital Bleeding Disorders and COVID-19—A Systematic Literature Review	6
Factor VIII and Factor IX Activity Measurements for Hemophilia Diagnosis and Related Treatments	6
Hereditary Angioedema: The Clinical Picture of Excessive Contact Activation	6
Viscoelastic Management of Coagulopathy during the Perioperative Period of Liver Transplantation	6
Variable Performance of Lupus Anticoagulant Testing: The Australasian/Asia-Pacific Experience	6
Plasma Kallikrein as a Forgotten Clotting Factor	6
Risk Factors for Antiphospholipid Antibodies and Antiphospholipid Syndrome	6
The Pitfalls of Global Hemostasis Assays in Myeloproliferative Neoplasms and Future Challenges	6
	6
Clinical, Laboratory Aspects and Management of Factor X Deficiency	6
Application of Activators Ecarin and Factor Xa in Thrombelastography for Measurement of Anticoagulant Effect of Direct Oral Anticoagulants Using TEG 5000	6
Thrombosis Risk Assessment in Myeloproliferative Neoplasm—Is There a Role for Viscoelastic Testing?	6
2023 Eberhard F. Mammen Award Announcements: Part II–Young Investigator Awards	6
Platelet Function in Acute Kidney Injury: A Systematic Review and a Cohort Study	6
Association of the Neutrophil-to-Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio, Lymphocyte-to-Monocyte Ratio, and Monocyte-to-High-Density Lipoprotein Cholesterol Ratio with In Situ Vena Cava Thrombo	6
Laboratory Evaluation of Antithrombin, Protein C, and Protein S	6
The Novel C-Terminal Cystine Knot (Exon 52) VWF p.Cys2771Phe Variant Produces a Type 2A von Willebrand Factor Multimer Pattern with an Apparent Dimerization Defect	6
Against Therapeutic Anticoagulation in Critically Ill COVID-19 Patients	6
Rebalanced hemostasis, bleeding and thrombosis in liver disease: a comprehensive review of pathophysiology, management and future perspectives	6
Antiphospholipid Syndrome in Patients with Venous Thromboembolism	5
Impact of Viral Infections on the Hemostatic System	5
Recurrent Bleeding after Cervical Surgery with Quebec Platelet Disorder: Case Report and Literature Review	5
What Role Does Microthrombosis Play in Long COVID?	5
Platelets: Physiology and Biochemistry	5
Viscoelastic Testing in the Clinical Management of Subarachnoid Hemorrhage and Intracerebral Hemorrhage	5
Thrombosis in Pregnant Women with Hematological Malignancies: A Case-Based Review	5
100 Years of von Willebrand Disease: Celebrating a Significant Milestone in von Willebrand Disease Diagnostics and Management	5
Vascular Pathogenesis in Acute and Long COVID: Current Insights and Therapeutic Outlook	5
Dosing, Monitoring, Blood Product Utilization, and Thromboembolic Complications of Four-Factor Prothrombin Complex Concentrate as Part of an Institutional Protocol in Pediatric Cardiac Surgery: A Retr	5
Anticoagulation with Intravenous Direct Thrombin Inhibitors in Pediatric Extracorporeal Membrane Oxygenation: A Systematic Review of the Literature	5
Monitoring Hemostatic Function during Cardiac Surgery with Point-of-Care Viscoelastic Assays: A Narrative Review	5
Has “D-Dimeritis” Worsened during the Coronavirus Disease 2019 Pandemic?	5
Isolated Low von Willebrand Factor Collagen-Binding Activity in Patients with a Positive Bleeding Phenotype: Diagnostic Implications for Von Willebrand Disease	5
Epidemiology and Predisposing Factors of Post-COVID Venous Thrombosis: A Concise Review	5
Venous Thromboembolism after Hospital Discharge: Temporal Trends in Baseline Characteristics, Prevention, Treatment, and 90-day Outcomes	5
Detecting Oxygenator Thrombosis in ECMO: A Review of Current Techniques and an Exploration of Future Directions	5
A Critical Reappraisal of the Bleeding Time	5
Human Genetic Variation in F3 and Its Impact on Tissue Factor–Dependent Disease	5
Platelets in Vascular Calcification: A Comprehensive Review of Platelet-Derived Extracellular Vesicles, Protein Interactions, Platelet Function Indices, and their Impact on Cellular Crosstalk	5
Red Blood Cells and Tranexamic Acid in the Inhibition of Fibrinolysis	5
Secondary Anticoagulation Use in Patients < 21 Years Old following Primary Anticoagulant Treatment for Provoked Venous Thromboembolism: Findings from the Kids-DOTT Trial	5
Classification Criteria for the Antiphospholipid Syndrome: Not the Same as Diagnostic Criteria for Antiphospholipid Syndrome	5
Pathogen Reduction Technologies and Their Impact on Metabolic and Functional Properties of Treated Platelet Concentrates: A Systematic Review	5
Assessment of Hemostatic Profile in Neonates with Intrauterine Growth Restriction: A Systematic Review of Literature	5
Is Vitamin D Deficiency Prothrombotic? A Systematic Review	5
Antiphospholipid Antibodies in Pregnancy: Maternal and Neonatal Implications	5
Reviewing the Rich History of Fibrin Clot Research with a Focus on Clinical Relevance	5
Hemostasis, Thrombosis, and Vascular Biology in Psychiatric Disorders	4
Platelet Contributions to the (Pre)metastatic Tumor Microenvironment	4
Red Blood Cells are Critical for Hemostasis and Thrombosis	4
Diagnosis and Treatment of Autoimmune Acquired Coagulation Factor Deficiencies: An Evidence-Based Review of Japanese Practice	4
	4
Evolution of Hemostasis Testing: A Personal Reflection Covering over 40 Years of History*	4
Optimizing and Extending the Risk-Adapted Management of Acute Pulmonary Embolism beyond the Acute Phase: Progress in Pulmonary Embolism Research	4
A Tragedy within a Tragedy: How the Inappropriate Request for D-dimer during the COVID-19 Pandemic Might Have Harmed So Many People	4
Post COVID-19 Large Vessel Vasculopathy in a Previously Healthy Young Male	4
Clinical Studies with Anticoagulants that Have Changed Clinical Practice	4
Measuring Quality of Life after Venous Thromboembolism: Who, When, and How?	4
Neutrophil-Mediated Effects on Hemostasis and Thrombosis: Unraveling Their Complex Interaction in Thrombotic Events	4
Editorial Compilation XII	4
Laser-Induced Blood Coagulation for Surgical Application: A Scoping Review	4
Relative Hypercoagulopathy of the SARS-CoV-2 Beta and Delta Variants when Compared to the Less Severe Omicron Variants Is Related to TEG Parameters, the Extent of Fibrin Amyloid Microclots, and the Se	4
Targeting the Contact Pathway of Coagulation for the Prevention and Management of Medical Device-Associated Thrombosis	4
Prone Position and the Risk of Venous Thrombosis in COVID-19 Patients with Respiratory Failure	4
From the Discovery of ADAMTS13 to Current Understanding of Its Role in Health and Disease	4
Sudden Cardiac Arrest and Death in Sports: An Updated Overview of Epidemiology, Etiologies, and Prevention Strategies, with Emphasis on Inherited Cardiomyopathies	4
The Evolution of Hemophilia Pharmacological Treatments and Therapeutic Targets at the Turn of the Third Millennium	4
New Horizons in Fetal and Neonatal Alloimmune Thrombocytopenia	4
Coronary Thrombosis with Distal Embolization in a Young Patient after Orthopaedic Surgery: An Informative Case Report	4
Causal Relationships of Circulating Inflammatory Proteins and Portal Vein Thrombosis: A Mendelian Randomization Study	4
Causal Associations Between Cardiovascular Risk Factors and Venous Thromboembolism	4
Heparins May Not Be the Optimal Anticoagulants for Sepsis and Sepsis-Associated Disseminated Intravascular Coagulation	4
Comparative Analysis of Four Risk Stratification Models to Identify Patients with Acute Pulmonary Embolism at Risk of Short-term Mortality	4
Editorial Compilation—XV	4
Viscoelastic Hemostatic Assays in Sepsis: From Pathophysiology to Potential Clinical Implications	4
Correlation between Phenotype and Coagulation Factor Activity Level in Rare Bleeding Disorders: A Systematic Review	4
	4
Hemostatic and Inflammatory Biomarkers are Associated with Functional Limitations after Venous Thromboembolism: A Prospective Cohort Study	4
Prophylaxis of Venous Thromboembolism in Children: A Systematic Review	4
	4
Pearls and Pitfalls in the Measurement of Direct Oral Anticoagulants	4
Role of Viscoelastic and Conventional Coagulation Tests for Management of Blood Product Replacement in the Bleeding Patient	4
The ABO Blood System and Associated Implications for Hemostasis and Thrombosis	4
Risk Factors of Catheter-Related Thrombosis in Elderly Patients with Lung Cancer Based on Thromboelastography: A Retrospective, Case-Control Study	4
Antiphospholipid Antibodies in Mental Disorders	4
Recommendations on the use of COVID-19 Convalescent Plasma to Treat Immunocompromised Patients	3
Risk of Venous Thromboembolism by Cancer Type: A Network Meta-Analysis	3
Are Antiphospholipid Antibodies a Surrogate Risk Factor for Thrombosis in Sepsis?	3
Patient Perspective on Disease Burden and Gene Therapy for Hemophilia A and B: The “Haemvolution for Patients” Italian Survey	3